News
Digital technology may be on the verge of ‘breaking out’ for schizophrenia treatment, but numerous questions will need to be ...
The usual suspect has the Bears winning the NFC North, and fans of the Packers, Vikings, Lions and Commanders among others ...
Courtney Palmer went viral for a TikTok explaining why it's "princess behavior" to ignore your server. But her magnum opus is ...
Prompt engineering is the practice of priming LLM queries to increase quality and reliability. Users cannot fully safeguard ...
A year after an assassination attempt shocked Butler County, the motives of the gunman, Thomas Matthew Crooks, remain largely ...
Anisimova's parents and sister are from Russia, but she was born in New Jersey. Here's more on Anisimova's family tree, ...
MapLight Therapeutics today announced the initiation of a Phase 2 study to evaluate the efficacy, safety and tolerability of ML-007C-MA, an investigational novel M1/M4 agonist, as a potential ...
Sometimes, the search for love can leave you feeling drained, disillusioned, or just plain tired. Maybe you’ve stopped trying ...
NMRA-861 has demonstrated a potentially best-in-class pharmacological profile and robust activity in preclinical efficacy models. NMRA-861 was safe and well-tolerated in pre-clinical toxicology ...
As politics in the UK becomes increasingly fraught, we could all learn from Richard Haas’s ‘ten habits’ of good citizens ...
"WWE SmackDown" finished off the company's week in Pittsburgh with some Fourth of July fireworks. This show was all about tag ...
MapLight Therapeutics initiates phase 2 ZEPHYR study of M1/M4 muscarinic agonist ML-007C-MA to treat schizophrenia: Redwood City Thursday, July 10, 2025, 13:30 Hrs [IST] MapLight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results